Biotech company Sarepta Therapeutics (NASDAQ:SRPT) announced better-than-expected revenue in Q4 CY2024, with sales up 65.9% year on year to $658.4 million. Its non-GAAP profit of $1.90 per share was 7.8% below analysts’ consensus estimates.
Online marketplace eBay (NASDAQ:EBAY) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $2.58 billion. On the other hand, next quarter’s revenue guidance of $2.54 billion was less impressive, coming in 2.3% below analysts’ estimates. Its non-GAAP profit of $1.25 per share was 4.3% above analysts’ consensus estimates.
Leading designer of graphics chips Nvidia (NASDAQ:NVDA) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 77.9% year on year to $39.33 billion. Guidance for next quarter’s revenue was optimistic at $43 billion at the midpoint, 2.1% above analysts’ estimates. Its non-GAAP profit of $0.89 per share was 5.2% above analysts’ consensus estimates.
Digital medical services platform Teladoc Health (NYSE:TDOC) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 3% year on year to $640.5 million. On the other hand, next quarter’s revenue guidance of $618.5 million was less impressive, coming in 2.4% below analysts’ estimates. Its GAAP loss of $0.28 per share was 26.1% below analysts’ consensus estimates.
Aircraft leasing company FTAI Aviation (NASDAQ:FTAI) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 59.5% year on year to $498.8 million. Its GAAP profit of $0.84 per share was 6.1% below analysts’ consensus estimates.
Casual salad chain Sweetgreen (NYSE:SG) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 5.1% year on year to $160.9 million. On the other hand, next quarter’s revenue guidance of $164.5 million was less impressive, coming in 7.7% below analysts’ estimates. Its GAAP loss of $0.25 per share was 16.4% below analysts’ consensus estimates.
Data warehouse-as-a-service Snowflake (NYSE:SNOW) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 27.4% year on year to $986.8 million. Its non-GAAP profit of $0.30 per share was 67.3% above analysts’ consensus estimates.
Online legal service provider LegalZoom (NASDAQ:LZ) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $161.7 million. Guidance for next quarter’s revenue was better than expected at $177 million at the midpoint, 1% above analysts’ estimates. Its GAAP profit of $0.07 per share was in line with analysts’ consensus estimates.
Artificial intelligence (AI) software company C3.ai (NYSE:AI) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 26% year on year to $98.78 million. The company expects next quarter’s revenue to be around $108.6 million, close to analysts’ estimates. Its non-GAAP loss of $0.12 per share was 52% above analysts’ consensus estimates.
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 35% year on year to $282.6 million. The company expects next quarter’s revenue to be around $221.5 million, coming in 1.3% above analysts’ estimates. Its GAAP profit of $0.01 per share was significantly above analysts’ consensus estimates.